Dergiler / art / 2019 / Cilt: 34 - Sayı: 2

Bone Mineral Loss and Fracture in Sarcoidosis: A Systematic Review and Meta-Analysis

Dergi
art
Sayfa
130–140
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, based on the currently available studies with heterogeneity in between, the conclusion for the osteoporosis screening and fracture risk assessment of patients with sarcoidosis cannot be drawn until more studies are available.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: This meta-analysis aims to investigate the possibility of bone mineral loss and fracture in sarcoidosis.
📊
Temel Bulgular & Veri:Materials and methods: A comprehensive search of the MEDLINE and Embase databases was performed from inception through August 2017.
💡
Sonuç & Katkı:However, based on the currently available studies with heterogeneity in between, the conclusion for the osteoporosis screening and fracture risk assessment of patients with sarcoidosis cannot be drawn until more studies are available.
🔬Tür:Laboratuvar & Saha Deneyi
📍Kapsam:2017 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: This meta-analysis aims to investigate the possibility of bone mineral loss and fracture in sarcoidosis. Materials and methods: A comprehensive search of the MEDLINE and Embase databases was performed from inception through August 2017. The inclusion criterion was observational studies evaluating the association between sarcoidosis and bone mineral density (BMD) or fracture. The pooled odds ratio (OR) of fracture, standardized mean difference (SMD) of volumetric BMD and areal BMD, and their 95% confidence interval (CI) were calculated using a random-effects meta-analysis to compare risk between sarcoidosis and controls. The between-study heterogeneity of effect-size was quantified using the Q statistic and I2. Results: Data were extracted from 10 studies involving a total of 6,448 sarcoidosis patients and 77,857 controls. The pooled result demonstrated no significant increased risk of fracture in sarcoidosis patients compared with controls (OR=1.68; 95% CI: 0.85-3.31, p value=0.14, I2=72%). There were no differences between the patients and controls in areal BMD (SMD= 0.21 g/cm2; 95% CI: -0.12-0.54, p value= 0.22, I2=0%) or volumetric BMD (SMD= 0.04 mg/cm3; 95% CI: -0.51-0.58, p value=0.89, I2=83%). Conclusion: Our study has not shown an increased risk of fracture or bone mineral loss in sarcoidosis. However, based on the currently available studies with heterogeneity in between, the conclusion for the osteoporosis screening and fracture risk assessment of patients with sarcoidosis cannot be drawn until more studies are available.

🔖

Bu Makaleye Atıf Yap

YONG, W. C., UPALA, S., SANGUANKEO, A. (2019). Bone Mineral Loss and Fracture in Sarcoidosis: A Systematic Review and Meta-Analysis. art, Cilt: 34 - Sayı: 2, 130–140. https://ajindex.com/articles/150418

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Thomas KW, Hunninghake GW. Sarcoidosis. JAMA 2003;289:3300-3
  2. Sweiss NJ, Lower EE, Korsten P, Niewold TB, Favus MJ, Baughman RP. Bone health issues in sarcoidosis. Curr Rheumatol Rep 2011;13:265-72
  3. Romme EA, Smeenk FW, Rutten EP, Wouters EF. Osteoporosis in chronic obstructive pulmonary disease. Expert Rev Respir Med 2013;7:397-410. 4. de Vries F, van Staa TP, Bracke MS, Cooper C, Leufkens HG, Lammers JW. Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J 2005;25:879-84
  4. Mohammad A, Lohan D, Bergin D, Mooney S, Newell J, O’Donnell M, et al. The prevalence of vertebral fracture on vertebral fracture assessment imaging in a large cohort of patients with rheumatoid arthritis. Rheumatology (Oxford) 2014;53:821-7
  5. Dirven L, van den Broek M, van Groenendael JH, de Beus WM, Kerstens PJ, Huizinga TW, et al. Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis. BMC Musculoskelet Disord 2012;13:125. 7. van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:3104-12
  6. Sambrook PN, Geusens P. The epidemiology of osteoporosis and fractures in ankylosing spondylitis. Ther Adv Musculoskelet Dis 2012;4:287-92
  7. Vosse D, Landewé R, van der Heijde D, van der Linden S, van Staa TP, Geusens P. Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study. Ann Rheum Dis 2009;68:1839-42
  8. Almehed K, Hetényi S, Ohlsson C, Carlsten H, Forsblad-d’Elia H. Prevalence and risk factors of vertebral compression fractures in female SLE patients. Arthritis Res Ther 2010;12:153
  9. Bultink IE, Harvey NC, Lalmohamed A, Cooper C, Lems WF, van Staa TP, et al. Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom. Osteoporos Int 2014;25:1275-83
  10. Vázquez MA, Lopez E, Montoya MJ, Giner M, Pérez- Temprano R, Pérez-Cano R. Vertebral fractures in patients with inflammatory bowel disease compared with a healthy population: a prospective case-control study. BMC Gastroenterol 2012;12:47
  11. Tatsuno I, Suzuki S, Yoshida T, Nagano H, Hashimoto N, Mayama T,et al. Disease-related risk of vertebral fracture during glucocorticoid treatment of collagen vascular diseases. J Rheumat